Chiron Signs License Agreement with Axeda for Device Relationship Management of Blood Screening Devices.Business Editors/High-Tech Writers MANSFIELD, Mass.--(BUSINESS WIRE)--Jan. 7, 2003 Enables Proactive Remote Diagnostics Vehicle Diagnostics Vehicle diagnostics enables a mechanic to diagnose the exact mechanical condition of the vehicle and its systems and components. Remote Diagnostics enables to perform such diagnosis without requiring the vehicle to physically be present for checkup. to Improve Customer Service and Uptime of Critical Medical Instruments Axeda Systems Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :XEDA), the world's leading provider of device relationship management (DRM (1) (Digital Radio Mondiale) A digital audio broadcasting (DAB) system for AM radio in Europe. See HD Radio. (2) (Digital Rights M ) enterprise software and services, announced today that Chiron Corporation Chiron Corporation was a multinational biotechnology firm based in Emeryville, California that was acquired by Novartis International AG on April 20 2006. It had offices and facilities in eighteen countries on five continents. , a global pharmaceutical company and market leader in blood screening for hepatitis C Hepatitis C Definition Hepatitis C is a form of liver inflammation that causes primarily a long-lasting (chronic) disease. Acute (newly developed) hepatitis C is rarely observed as the early disease is generally quite mild. and HIV-1, has licensed the Axeda DRM(TM) System to enable the proactive monitoring, service and support of its Procleix(R) System. In worldwide use today at major blood centers like the American Red Cross American Red Cross: see Red Cross. , Chiron's Procleix System currently tests more than 70% of the U.S. blood supply. Chiron service professionals will use the Axeda DRM system to remotely monitor Procleix Instrumentation installed at customer facilities, improving service response times and instrument uptimes of these critical medical instruments. "At Axeda we share Chiron's commitment to quality, innovation and excellence, and we are focused on helping the world's device manufacturers employ DRM technology to become truly proactive enterprises," said Robert M. Russell Jr., CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Axeda Systems Inc. "We are extremely pleased that Chiron, a scientific innovator and the global leader in their field, has joined the growing list of leading providers of medical and scientific instruments that have chosen Axeda." Nucleic acid nucleic acid, any of a group of organic substances found in the chromosomes of living cells and viruses that play a central role in the storage and replication of hereditary information and in the expression of this information through protein synthesis. testing (NAT (Network Address Translation) An IETF standard that allows an organization to present itself to the Internet with far fewer IP addresses than there are nodes on its internal network. ) is a new, highly sensitive Adj. 1. highly sensitive - readily affected by various agents; "a highly sensitive explosive is easily exploded by a shock"; "a sensitive colloid is readily coagulated" testing approach for improving the safety of the world's blood supply. Moving quickly from concept to commercialization, Chiron and its collaborator, Gen-Probe Incorporated, developed the Procleix(R) System, a NAT assay and instrument system, in just three years. The Procleix System has proven to significantly reduce the risk of contracting hepatitis C and HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. from blood transfusions. Every year approximately 35 million blood donations are tested in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , the European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the European Community , and Asia-Pacific. As NAT is adopted in major markets throughout the world, the Procleix System is rapidly gaining acceptance as a leading product for the blood screening market. The Axeda DRM system is a distributed enterprise software solution that lets service organizations proactively monitor, diagnose, repair and re-supply intelligent devices when remotely deployed at customer sites. Unlike telephone-based systems, Axeda DRM leverages patent-pending Firewall-Friendly(TM) Internet communications technology Noun 1. communications technology - the activity of designing and constructing and maintaining communication systems engineering, technology - the practical application of science to commerce or industry to securely transmit instrument data from remote instruments to service representatives, alerting them if an instrument is operating outside preset performance standards. Axeda DRM helps minimize support calls and time on the phone, reduces the number of costly, unscheduled or unnecessary service visits, and increases device uptime to further enhance customer productivity and satisfaction. DRM also enables new, high-value managed-service offerings such as automated consumable replenishment, system upgrades and pay-for-use billing approaches such as cost-per-reportable programs. Ultimately, Axeda DRM enables full-lifecycle feedback that can be used to benefit multiple parts of the business including product development, marketing, sales, operations, and manufacturing. Please contact Axeda at info@axeda.com or call +1-508-337-9200. Visit www.axeda.com for more information. About Chiron Corporation Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a difference in people's lives. The company has a strategic focus on cancer and infectious disease Infectious disease A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions. . Chiron applies its advanced understanding of the biology of cancer and infectious disease to develop products from its platforms in proteins, small molecules and vaccines. The company commercializes its products through three business units: biopharmaceuticals, vaccines and blood testing. For more information about Chiron, visit the company's website at www.chiron.com. For more information about Chiron Blood Testing, visit www.ebloodbank.com. About Axeda Axeda Systems Inc. (NASDAQ: XEDA) is the world's leading provider of device relationship management (DRM) enterprise software and services. Axeda helps businesses become more competitive by using the Internet to extract real-time information hidden in their intelligent devices. The company's flagship product, the Axeda Device Relationship Management System(TM), is a distributed software solution that lets businesses remotely monitor, manage and service intelligent devices, deployed around the world, allowing them to optimize their service, development, sales and manufacturing operations. Axeda customers are Global 2000 companies in many markets including Medical Instrument, Enterprise Technology, Printer and Copier, Industrial and Building Automation, and Semiconductor Equipment industries. Axeda has sales and service offices in the US, Europe and Japan, and distribution partners worldwide. More information about Axeda is available at www.axeda.com. About Device Relationship Management Everyday intelligent devices such as copiers, elevators, vending machines, building control units, medical devices, computers and storage systems, and industrial machines are an important new source of business information. Device relationship management systems allow companies to tap into this valuable information anytime anywhere. Pioneered by Axeda, device relationship management technology provides a distributed information management system that leverages the Internet to allow timely, accurate, and unbiased information to be communicated automatically between intelligent devices, wherever they are deployed around the world, and service personnel or enterprise business systems. Device relationship management helps turn reactive businesses into proactive businesses providing new sources of revenue, increased operational efficiency and lower costs, with an ROI (Return On Investment) The monetary benefits derived from having spent money on developing or revising a system. In the IT world, there are more ways to compute ROI than Carter has liver pills (and for those of you who never heard of that expression, it means a lot). that is often measured in months. (C) 2003 Axeda Systems. All rights reserved. Axeda, Axeda Systems, Axeda DRM, Axeda Device Relationship Management System, Axeda Agents, Axeda Applications, Axeda Enterprise, Axeda Supervisor, Automatic eCommerce, Firewall-Friendly, and Access. Insight. In Real Time. are trademarks of Axeda Systems. DRM Leadership Alliance, DRM Leadership Forum, DRM Leadership Council, and DRM Integration Program are service marks of Axeda Systems. The Axeda logo and stylized styl·ize tr.v. styl·ized, styl·iz·ing, styl·iz·es 1. To restrict or make conform to a particular style. 2. To represent conventionally; conventionalize. bitstream design are trademarks of Axeda Systems. All other trademarks are either property of Axeda Systems or property of their respective owners. This press release may contain certain forward-looking statements that relate to Axeda's future performance. These forward-looking statements include, but are not limited to, those regarding Axeda's products and markets, product functionality in future installations and benefits derived therefrom, and may include implied statements concerning market acceptance of Axeda's products and its growing leadership role in the DRM market. Such statements are subject to a number of risks and uncertainties that may cause the actual events or future results to differ from those discussed herein. Such factors include, among others: Axeda's customers' ability to implement or integrate Axeda's DRM solutions successfully and in a timely fashion, receive expected functionality and performance, or achieve benefits attributable to Axeda's DRM solutions; uncertainties in the market for DRM products and the potential for growth in the DRM market; the long sales cycle for DRM products; limited distribution channels; the difficulty of protecting proprietary rights; present and future competition; and Axeda's ability to manage technological change and respond to evolving industry standards. Investors are advised to read Axeda's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. and quarterly reports on Form 10-Q Form 10-Q See 10-Q. filed with the Securities and Exchange Commission, particularly those sections entitled "Factors Affecting Operating Results" and "Risk Factors" for a more complete discussion of these and other risks and uncertainties. Axeda assumes no obligation to update the forward-looking information contained in this press release. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion